Literature DB >> 19657667

One year outcome of manual alcohol-assisted removal of Salzmann's nodular degeneration.

Anna M Roszkowska1, Pietro Colosi, Letteria De Grazia, Eliana Mirabelli, Giovanni Romeo.   

Abstract

BACKGROUND: To analyze visual and refractive modifications and corneal topography changes in a patient treated for bilateral advanced Salzmann's nodular degeneration (SND).
METHODS: A forty-three-year-old man with bilateral advanced SND underwent manual, alcohol-assisted removal of the altered layer. Visual acuity, refraction, corneal topography and corneal aberrations were examined before and after the treatment after 7 days and 1, 6 and 12 months.
RESULTS: The uncorrected visual acuity changed from 0.1 to 1.0 in both eyes. Refraction changed from sphere +3.00 and cylinder +4.50 x 180 degrees in the right eye and sphere +6 and cylinder +4.0 x 170 degrees in the left eye to bilateral emetropia. Corneal topography recovered from an extremely flat profile to a normal shape and it was unvaried during the follow-up period. Main topographic indices, highly altered before the treatment, normalized and were normal at control examinations. The quality of vision improved significantly with reduction of high-order aberrations from RMS of 5,07 microm to 0,66 microm in the right eye and RMS of 4,89 microm to 0,57 microm in the left eye respectively.
CONCLUSIONS: Salzmann nodules produce an impressive central corneal flattening with high hyperopic refractive error and significant increment of corneal aberrations. After manual removal of the altered layer, the visual and refractive recovery, corneal topography and aberrometry normalization were immediate and stable during the observational period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657667     DOI: 10.1007/s00417-009-1154-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Long-term outcome of excimer laser phototherapeutic keratectomy for treatment of Salzmann's nodular degeneration.

Authors:  Sujata Das; Achim Langenbucher; Pavel Pogorelov; Barbara Link; Berthold Seitz
Journal:  J Cataract Refract Surg       Date:  2005-07       Impact factor: 3.351

2.  Corneal surface topography and associated visual performance with INTACS for myopia: phase III clinical trial results. The INTACS Study Group.

Authors:  D K Holmes-Higgin; T E Burris
Journal:  Ophthalmology       Date:  2000-11       Impact factor: 12.079

3.  The epithelial flap for photorefractive keratectomy.

Authors:  S Shah; A R Sebai Sarhan; S J Doyle; C T Pillai; H S Dua
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 4.  Salzmann's nodular degeneration of the cornea: a review and case series.

Authors:  Sujata Das; Barbara Link; Berthold Seitz
Journal:  Cornea       Date:  2005-10       Impact factor: 2.651

5.  Phototherapeutic keratectomy in Salzmann's nodular degeneration.

Authors:  Johan Germundsson; Per Fagerholm
Journal:  Acta Ophthalmol Scand       Date:  2004-04

6.  Superficial keratectomy with mitomycin-C for the treatment of Salzmann's nodules.

Authors:  Patrick J Bowers; Marianne O Price; Steven S Zeldes; Francis W Price
Journal:  J Cataract Refract Surg       Date:  2003-07       Impact factor: 3.351

7.  Reduction of hyperopia associated with manual excision of Salzmann's nodular degeneration.

Authors:  J G Oster; R F Steinert; R N Hogan
Journal:  J Refract Surg       Date:  2001 Jul-Aug       Impact factor: 3.573

  7 in total
  3 in total

1.  [Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy].

Authors:  R Sundmacher
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

2.  Recurrence of Salzmann nodular degeneration of the cornea in a Crohn's disease patient.

Authors:  Anna M Roszkowska; Rosaria Spinella; Pasquale Aragona
Journal:  Int Ophthalmol       Date:  2012-10-12       Impact factor: 2.031

3.  Salzmann nodular degeneration: prevalence, impact, and management strategies.

Authors:  Vikram Paranjpe; Anat Galor; Pedro Monsalve; Sander R Dubovy; Carol L Karp
Journal:  Clin Ophthalmol       Date:  2019-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.